 |
|
Efficacy and Safety of Intravitreal Dexamethasone Implants for Treatment of Refractory Diabetic Macular Edema
Erkan Unsal, Kadir Eltutar, Pınar Sultan, Sezin Ozdogan Erkul, Ozen Ayranci Osmanbasoglu
Korean J Ophthalmol. 2017;31(2):115-122. Published online 2017 Mar 21 DOI: https://doi.org/10.3341/kjo.2017.31.2.115
|
|
Citations to this article as recorded by
 Baseline intraocular pressure: an independent risk factor in severe steroid-induced ocular hypertension after intravitreal dexamethasone implant
Won Jeong Cho, Jun Mo Lee, Hyoung Won Bae, Chan Yun Kim, Gong Je Seong, Wungrak Choi
Graefe's Archive for Clinical and Experimental Ophthalmology.2024; 262(4): 1231. CrossRef Changes in intraocular pressure following intravitreal dexamethasone implant in patients with history of glaucoma filtration surgery
Dong Kyu Lee, Joo Yong Lee, Se Joon Woo, Yong Sok Ji, Christopher Seungkyu Lee
Graefe's Archive for Clinical and Experimental Ophthalmology.2024;[Epub] CrossRef Diabetic Macular Oedema Guidelines: An Australian Perspective
Yew Sen Yuen, Jagjit Singh Gilhotra, Michelle Dalton, Jaskirat S. Aujla, Hemal Mehta, Sanj Wickremasinghe, Gurmit Uppal, Jennifer Arnold, Fred Chen, Andrew Chang, Samantha Fraser-Bell, Lyndell Lim, Janika Shah, Ellie Bowditch, Geoffrey K. Broadhead, Paolo
Journal of Ophthalmology.2023; 2023: 1. CrossRef Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology
Noura Al Qassimi, Igor Kozak, Maysoon Al Karam, Piergiorgio Neri, Patricio M. Aduriz-Lorenzo, Alaa Attawan, Mohamed Awadalla, Ahmed El Khashab, Mohamed Abdul-Nabi, Ammar Safar, Hanan Al Shamsi, Prasan Rao, Madhav Rao, Amr Farid, Avinash Gurbaxani
Ophthalmology and Therapy.2022; 11(5): 1937. CrossRef Axial Length as a Risk Factor for Steroid-Induced Ocular Hypertension
Wungrak Choi, Jung Dong Kim, Hyoung Won Bae, Chan Yun Kim, Gong Je Seong, Min Kim
Yonsei Medical Journal.2022; 63(9): 850. CrossRef Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation
Wungrak Choi, Hyoung Won Bae, Hye Jung Shin, Eun Woo Kim, Chan Yun Kim, Min Kim, Gong Je Seong
British Journal of Ophthalmology.2021; : bjophthalmol-2020-318401. CrossRef Safety and long-term outcomes of repeated dexamethasone intravitreal implant (OZURDEX®) for the management of macular edema: Real-life study
Meriem Abdellaoui, Meriem El Bahloul, Ahmed Bennis, Fouad Chraïbi, Adil Najdi, IdrissAndaloussi Benatiya
Egyptian Retina Journal.2021; 8(1): 26. CrossRef Treatment of Eyes With Diabetic Macular Edema That Had a Suboptimal Response to Antivascular Endothelial Growth Factor Therapy: 2-mg Intravitreal Triamcinolone Acetonide vs 0.7-mg Dexamethasone Implant
Brandon Kuley, Philip P. Storey, Maitri Pancholy, Turner D. Wibbelsman, Anthony Obeid, Carl Regillo, Sunir Garg
Journal of VitreoRetinal Diseases.2020; 4(5): 372. CrossRef Risk factors for ocular hypertension after intravitreal dexamethasone implantation in diabetic macular edema
Moon Young Choi, Jin-woo Kwon
Scientific Reports.2020;[Epub] CrossRef The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis
Victor. A. de Vries, Fabiana L. Bassil, Wishal. D. Ramdas
Scientific Reports.2020;[Epub] CrossRef Age as a risk factor for steroid-induced ocular hypertension in the non-paediatric population
Wungrak Choi, Hyoung Won Bae, Eun Young Choi, Minha Kim, Eun Woo Kim, Chan Yun Kim, Min Kim, Gong Je Seong
British Journal of Ophthalmology.2020; 104(10): 1423. CrossRef Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema
Havva Kaldırım, Fatma Savur, Ahmet Kırgız, Kürşat Atalay
Korean Journal of Ophthalmology.2020; 34(5): 383. CrossRef Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
Verónica Castro-Navarro, Enrique Cervera-Taulet, Catalina Navarro-Palop, Clara Monferrer-Adsuara, Laura Hernández-Bel, Javier Montero-Hernández
BMC Ophthalmology.2019;[Epub] CrossRef Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients
Wungrak Choi, Sung Eun Park, Hyun Goo Kang, Suk Ho Byeon, Sung Soo Kim, Hyoung Jun Koh, Sungchul Lee, Gong Je Seong, Chan Yun Kim, Min Kim
British Journal of Ophthalmology.2019; 103(10): 1380. CrossRef Healthcare Utilization and Treatment Patterns in Diabetic Macular Edema in Korea: a Retrospective Chart Review
Kyu Hyung Park, Yun Young Kim, Young Joon Jo, Jaeryung Oh, Joo Eun Lee, Ji Eun Lee, Dong Ho Park, Se Woong Kang, Won Ki Lee, Ha Kyoung Kim, Michael Adena, Jonathan Tan, Si Dong Kim
Journal of Korean Medical Science.2019;[Epub] CrossRef Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up study
Marc Menezo, Manuel Roca, Víctor Menezo, Isabel Pascual
Current Medical Research and Opinion.2019; 35(12): 2111. CrossRef Simple technique for management of anterior chamber‐migrated Ozurdex® implant
Sung Hoon Lee, Hyungoo Kang, Suk Ho Byeon, Sung Soo Kim, Hyoung Jun Koh, Sung Chul Lee, Min Kim
Acta Ophthalmologica.2018;[Epub] CrossRef Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection
Jun Zhou, Zheng Liu, Meng Chen, Zhi-Heng Luo, Yun-Qiu Li, Guang-Ying Qi, Tao Liu
Diabetes Therapy.2018; 9(6): 2393. CrossRef Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
Claudio Bucolo, Lucia Gozzo, Laura Longo, Silvana Mansueto, Daniela Cristina Vitale, Filippo Drago
Journal of Pharmacological Sciences.2018; 138(4): 219. CrossRef Polymeric, injectable, intravitreal hydrogel devices for posterior segment applications and interventions
Muhammed Anwary, Pradeep Kumar, Lisa C. du Toit, Yahya E. Choonara, Viness Pillay
Artificial Cells, Nanomedicine, and Biotechnology.2018; 46(sup2): 1074. CrossRef Pharmacological Management of Diabetic Macular Edema in Real-Life Observational Studies
Laurent Kodjikian, David Bellocq, Thibaud Mathis
BioMed Research International.2018; 2018: 1. CrossRef Short-term Effect of Intravitreal Dexamethasone Implant on Diabetic Macular Edema with Epiretinal Membrane
Donghyoun Noh, Jang Hwan Ahn, Junyeop Lee, Min Sagong
Journal of Retina.2017; 2(2): 68. CrossRef
|